Washington, DC 20006-5349
HELPLINE
At the end of October of 2017, Dr. H. Richard Alexander, esteemed surgeon specializing in peritoneal mesothelioma, will be moving from his current institution, the…
In a statement released on Sunday, Bayer announced that Anetumab ravtansine, its antibody-drug conjugate (ADC) tested in mesothelioma, has missed its primary endpoint failing to…
Mesothelioma researcher and Meso Foundation grant recipient Prasad S. Adusumilli, MD, FACS, FCCP, of the Memorial Sloan Kettering Cancer Center (MSKCC) was an author on…
Dr. Anna Nowak, medical oncologist, is this year’s recipient of the Pioneer Award for her exceptional achievements and dedication in mesothelioma research. The Mesothelioma Applied…
Dr. Fred Hirsch, the CEO of the International Association for the Study of Lung Cancer (IASLC) and Professor at the University of Colorado School of…
In light of the newly released report by the Centers for Disease Control and Prevention (CDC) about the increase in mortality and morbidity of mesothelioma…
We are thrilled to announce that our executive director, Mary Hesdorffer, was selected as the recipient of the Gabriella Graham Patient Advocacy Award. This award…
Through partial funding by the Mesothelioma Applied Research Foundation, the National Comprehensive Cancer Network (NCCN) has published updated patient resources for malignant pleural mesothelioma. The…
The Meso Foundation announced today that at the end of this month, Dr. Lee Krug’s term on the Board of Directors (BOD) of the Mesothelioma…
Melissa Culligan, a member of the Mesothelioma Applied Research Foundation’s Board of Directors started her work on Saturday, December 3 at the 17th World Conference…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
